(firstQuint)A Safety and Effectiveness Study of Aroplatin in Patients With Advanced Solid Malignancies.

 Primary Objective: - Determine response rate (RR; complete and partial response [CR, PR]) and duration after therapy with Aroplatin cent in patients with advanced solid malignancies.

 Secondary Objective: - Determine the safety and tolerability of Aroplatin.

 A Safety and Effectiveness Study of Aroplatin in Patients With Advanced Solid Malignancies@highlight

To determine the rate of response and the duration of the response following therapy with Aroplatinin patients with advanced solid malignancies.

